FDA WARNING_LETTER - Rancho Cantera - November 26, 2012
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
On November 19 and 26, 2012, the FDA investigated Rancho Cantera, LLC, a dairy farm in Kent, Illinois, and found violations of the Federal Food, Drug, and Cosmetic Act. A Holstein dairy cow sold for slaughter on June 18, 2012, was found to have a violative residue of 0.11 ppm of ampicillin in its kidney, exceeding the 0.05 ppm tolerance level for penicillin in cattle, rendering the food adulterated under Section 402(a)(2)(C)(ii) of the FD&C Act.
The investigation also revealed insanitary conditions where medicated animals with harmful drug residues could enter the food supply, specifically due to the failure to maintain complete treatment records and a drug inventory system. Furthermore, the new animal drug Polyflex Ampicillin for injectable Suspension, NADA 55-030, was adulterated because it was used extralabelly without the supervision of a licensed veterinarian, violating 21 C.F.R. Part 530.11(a) and causing the drug to be unsafe and adulterated under Sections 512(a) and 501(a)(5) of the FD&C Act, respectively.
Rancho Cantera's December 5, 2012, response, which described steps to revise treatment protocols, was acknowledged.
ID · 75ba5181-1ebd-4ccb-bbf5-a42608a4d935
Full citation text and observation details available on the Dashboard.